nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR1D—meninx—sarcoma	0.0972	0.193	CbGeAlD
Methysergide—HTR1B—dura mater—sarcoma	0.0924	0.183	CbGeAlD
Methysergide—HTR1D—dura mater—sarcoma	0.0895	0.178	CbGeAlD
Methysergide—HTR7—pulmonary artery—sarcoma	0.0304	0.0604	CbGeAlD
Methysergide—HTR2A—pulmonary artery—sarcoma	0.019	0.0376	CbGeAlD
Methysergide—HTR1E—myometrium—sarcoma	0.0149	0.0296	CbGeAlD
Methysergide—Gravitational oedema—Epirubicin—sarcoma	0.0116	0.0233	CcSEcCtD
Methysergide—HTR2A—hindlimb—sarcoma	0.0115	0.0228	CbGeAlD
Methysergide—Gravitational oedema—Doxorubicin—sarcoma	0.0107	0.0216	CcSEcCtD
Methysergide—Leg edema—Epirubicin—sarcoma	0.0105	0.0211	CcSEcCtD
Methysergide—HTR2A—appendage—sarcoma	0.00984	0.0195	CbGeAlD
Methysergide—Leg edema—Doxorubicin—sarcoma	0.0097	0.0196	CcSEcCtD
Methysergide—HTR7—endothelium—sarcoma	0.00953	0.0189	CbGeAlD
Methysergide—SIGMAR1—mammary gland—sarcoma	0.00899	0.0178	CbGeAlD
Methysergide—Oliguria—Thiotepa—sarcoma	0.00761	0.0153	CcSEcCtD
Methysergide—Blood urea increased—Thiotepa—sarcoma	0.00662	0.0134	CcSEcCtD
Methysergide—SIGMAR1—myometrium—sarcoma	0.00638	0.0127	CbGeAlD
Methysergide—HTR2B—myometrium—sarcoma	0.00636	0.0126	CbGeAlD
Methysergide—HTR2A—endothelium—sarcoma	0.00594	0.0118	CbGeAlD
Methysergide—SIGMAR1—seminal vesicle—sarcoma	0.00576	0.0114	CbGeAlD
Methysergide—Blood urea increased—Mitoxantrone—sarcoma	0.00572	0.0115	CcSEcCtD
Methysergide—HTR1D—connective tissue—sarcoma	0.00565	0.0112	CbGeAlD
Methysergide—Urine output increased—Vincristine—sarcoma	0.00562	0.0113	CcSEcCtD
Methysergide—Polyuria—Vincristine—sarcoma	0.00514	0.0104	CcSEcCtD
Methysergide—HTR1A—hematopoietic system—sarcoma	0.0049	0.00971	CbGeAlD
Methysergide—SIGMAR1—smooth muscle tissue—sarcoma	0.00482	0.00957	CbGeAlD
Methysergide—HTR2B—smooth muscle tissue—sarcoma	0.00481	0.00955	CbGeAlD
Methysergide—Ataxia—Thiotepa—sarcoma	0.00479	0.00965	CcSEcCtD
Methysergide—HTR2B—skin of body—sarcoma	0.00475	0.00943	CbGeAlD
Methysergide—HTR7—hematopoietic system—sarcoma	0.00468	0.00928	CbGeAlD
Methysergide—Pain in extremity—Vincristine—sarcoma	0.00452	0.0091	CcSEcCtD
Methysergide—HTR7—connective tissue—sarcoma	0.0045	0.00894	CbGeAlD
Methysergide—Ataxia—Vincristine—sarcoma	0.00425	0.00856	CcSEcCtD
Methysergide—SIGMAR1—cardiac atrium—sarcoma	0.00416	0.00825	CbGeAlD
Methysergide—SIGMAR1—uterus—sarcoma	0.00414	0.00821	CbGeAlD
Methysergide—HTR2B—uterus—sarcoma	0.00413	0.00819	CbGeAlD
Methysergide—HTR7—smooth muscle tissue—sarcoma	0.00412	0.00818	CbGeAlD
Methysergide—Dysuria—Thiotepa—sarcoma	0.00412	0.0083	CcSEcCtD
Methysergide—Neutropenia—Dactinomycin—sarcoma	0.00408	0.00823	CcSEcCtD
Methysergide—Weight increased—Thiotepa—sarcoma	0.00401	0.00807	CcSEcCtD
Methysergide—Pleural effusion—Epirubicin—sarcoma	0.00369	0.00744	CcSEcCtD
Methysergide—Dysuria—Vincristine—sarcoma	0.00365	0.00736	CcSEcCtD
Methysergide—Neutropenia—Vincristine—sarcoma	0.00365	0.00736	CcSEcCtD
Methysergide—SIGMAR1—tendon—sarcoma	0.00362	0.00719	CbGeAlD
Methysergide—HTR2B—tendon—sarcoma	0.00362	0.00718	CbGeAlD
Methysergide—Hyperaesthesia—Epirubicin—sarcoma	0.0036	0.00726	CcSEcCtD
Methysergide—Neutropenia—Mitoxantrone—sarcoma	0.00355	0.00716	CcSEcCtD
Methysergide—Weight decreased—Vincristine—sarcoma	0.00353	0.00712	CcSEcCtD
Methysergide—SIGMAR1—bone marrow—sarcoma	0.00351	0.00697	CbGeAlD
Methysergide—Weight increased—Mitoxantrone—sarcoma	0.00346	0.00697	CcSEcCtD
Methysergide—Weight decreased—Mitoxantrone—sarcoma	0.00344	0.00693	CcSEcCtD
Methysergide—Pleural effusion—Doxorubicin—sarcoma	0.00341	0.00688	CcSEcCtD
Methysergide—Drowsiness—Mitoxantrone—sarcoma	0.00339	0.00683	CcSEcCtD
Methysergide—Hyperaesthesia—Doxorubicin—sarcoma	0.00333	0.00671	CcSEcCtD
Methysergide—HTR2A—embryo—sarcoma	0.00327	0.00649	CbGeAlD
Methysergide—Flushing—Dactinomycin—sarcoma	0.00325	0.00654	CcSEcCtD
Methysergide—Alopecia—Thiotepa—sarcoma	0.00311	0.00628	CcSEcCtD
Methysergide—HTR7—tendon—sarcoma	0.0031	0.00614	CbGeAlD
Methysergide—Alopecia—Dactinomycin—sarcoma	0.00309	0.00623	CcSEcCtD
Methysergide—Oliguria—Epirubicin—sarcoma	0.00307	0.00618	CcSEcCtD
Methysergide—SIGMAR1—testis—sarcoma	0.003	0.00595	CbGeAlD
Methysergide—Back pain—Thiotepa—sarcoma	0.00297	0.00598	CcSEcCtD
Methysergide—Neutropenia—Etoposide—sarcoma	0.00296	0.00596	CcSEcCtD
Methysergide—HTR2A—hematopoietic system—sarcoma	0.00292	0.00579	CbGeAlD
Methysergide—SIGMAR1—liver—sarcoma	0.00284	0.00563	CbGeAlD
Methysergide—Oliguria—Doxorubicin—sarcoma	0.00284	0.00572	CcSEcCtD
Methysergide—Ill-defined disorder—Dactinomycin—sarcoma	0.00282	0.00569	CcSEcCtD
Methysergide—HTR2A—connective tissue—sarcoma	0.00281	0.00557	CbGeAlD
Methysergide—Alopecia—Vincristine—sarcoma	0.00276	0.00556	CcSEcCtD
Methysergide—Malaise—Dactinomycin—sarcoma	0.00274	0.00553	CcSEcCtD
Methysergide—Alopecia—Mitoxantrone—sarcoma	0.00269	0.00542	CcSEcCtD
Methysergide—Blood urea increased—Epirubicin—sarcoma	0.00267	0.00538	CcSEcCtD
Methysergide—Convulsion—Thiotepa—sarcoma	0.00266	0.00536	CcSEcCtD
Methysergide—Back pain—Vincristine—sarcoma	0.00263	0.0053	CcSEcCtD
Methysergide—Myalgia—Thiotepa—sarcoma	0.00261	0.00526	CcSEcCtD
Methysergide—Arthralgia—Thiotepa—sarcoma	0.00261	0.00526	CcSEcCtD
Methysergide—Myalgia—Dactinomycin—sarcoma	0.00259	0.00522	CcSEcCtD
Methysergide—HTR2A—smooth muscle tissue—sarcoma	0.00257	0.0051	CbGeAlD
Methysergide—HTR7—testis—sarcoma	0.00256	0.00509	CbGeAlD
Methysergide—Back pain—Mitoxantrone—sarcoma	0.00256	0.00516	CcSEcCtD
Methysergide—Discomfort—Dactinomycin—sarcoma	0.00256	0.00516	CcSEcCtD
Methysergide—Oedema—Dactinomycin—sarcoma	0.00248	0.00501	CcSEcCtD
Methysergide—Blood urea increased—Doxorubicin—sarcoma	0.00247	0.00497	CcSEcCtD
Methysergide—Ill-defined disorder—Mitoxantrone—sarcoma	0.00246	0.00495	CcSEcCtD
Methysergide—Thrombocytopenia—Thiotepa—sarcoma	0.00245	0.00494	CcSEcCtD
Methysergide—Tachycardia—Thiotepa—sarcoma	0.00244	0.00492	CcSEcCtD
Methysergide—Thrombocytopenia—Dactinomycin—sarcoma	0.00243	0.0049	CcSEcCtD
Methysergide—HTR7—liver—sarcoma	0.00242	0.00481	CbGeAlD
Methysergide—Malaise—Mitoxantrone—sarcoma	0.00239	0.00481	CcSEcCtD
Methysergide—Thrombophlebitis—Epirubicin—sarcoma	0.00237	0.00478	CcSEcCtD
Methysergide—Convulsion—Vincristine—sarcoma	0.00236	0.00475	CcSEcCtD
Methysergide—Flushing—Etoposide—sarcoma	0.00235	0.00473	CcSEcCtD
Methysergide—Myalgia—Vincristine—sarcoma	0.00232	0.00467	CcSEcCtD
Methysergide—Convulsion—Mitoxantrone—sarcoma	0.00229	0.00463	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00228	0.0046	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00226	0.00456	CcSEcCtD
Methysergide—Arthralgia—Mitoxantrone—sarcoma	0.00225	0.00455	CcSEcCtD
Methysergide—Chest pain—Mitoxantrone—sarcoma	0.00225	0.00455	CcSEcCtD
Methysergide—Myalgia—Mitoxantrone—sarcoma	0.00225	0.00455	CcSEcCtD
Methysergide—Paraesthesia—Thiotepa—sarcoma	0.00225	0.00453	CcSEcCtD
Methysergide—Alopecia—Etoposide—sarcoma	0.00224	0.00451	CcSEcCtD
Methysergide—Discomfort—Mitoxantrone—sarcoma	0.00223	0.00449	CcSEcCtD
Methysergide—Somnolence—Thiotepa—sarcoma	0.00223	0.00449	CcSEcCtD
Methysergide—Oedema—Vincristine—sarcoma	0.00222	0.00447	CcSEcCtD
Methysergide—Dyspepsia—Thiotepa—sarcoma	0.0022	0.00444	CcSEcCtD
Methysergide—Thrombophlebitis—Doxorubicin—sarcoma	0.00219	0.00442	CcSEcCtD
Methysergide—SIGMAR1—lymph node—sarcoma	0.00218	0.00432	CbGeAlD
Methysergide—Thrombocytopenia—Vincristine—sarcoma	0.00217	0.00438	CcSEcCtD
Methysergide—HTR2B—lymph node—sarcoma	0.00217	0.00431	CbGeAlD
Methysergide—Oedema—Mitoxantrone—sarcoma	0.00216	0.00436	CcSEcCtD
Methysergide—Gastrointestinal disorder—Thiotepa—sarcoma	0.00216	0.00436	CcSEcCtD
Methysergide—Fatigue—Thiotepa—sarcoma	0.00216	0.00435	CcSEcCtD
Methysergide—Fatigue—Dactinomycin—sarcoma	0.00214	0.00432	CcSEcCtD
Methysergide—Pain—Thiotepa—sarcoma	0.00214	0.00431	CcSEcCtD
Methysergide—Constipation—Thiotepa—sarcoma	0.00214	0.00431	CcSEcCtD
Methysergide—Back pain—Etoposide—sarcoma	0.00213	0.0043	CcSEcCtD
Methysergide—Pain—Dactinomycin—sarcoma	0.00212	0.00428	CcSEcCtD
Methysergide—Thrombocytopenia—Mitoxantrone—sarcoma	0.00212	0.00427	CcSEcCtD
Methysergide—Tachycardia—Mitoxantrone—sarcoma	0.00211	0.00425	CcSEcCtD
Methysergide—Feeling abnormal—Thiotepa—sarcoma	0.00206	0.00416	CcSEcCtD
Methysergide—Pain in extremity—Epirubicin—sarcoma	0.00205	0.00413	CcSEcCtD
Methysergide—Feeling abnormal—Dactinomycin—sarcoma	0.00205	0.00413	CcSEcCtD
Methysergide—Gastrointestinal pain—Thiotepa—sarcoma	0.00205	0.00413	CcSEcCtD
Methysergide—Ill-defined disorder—Etoposide—sarcoma	0.00204	0.00412	CcSEcCtD
Methysergide—Gastrointestinal pain—Dactinomycin—sarcoma	0.00203	0.00409	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Vincristine—sarcoma	0.00202	0.00408	CcSEcCtD
Methysergide—Insomnia—Vincristine—sarcoma	0.00201	0.00405	CcSEcCtD
Methysergide—Paraesthesia—Vincristine—sarcoma	0.00199	0.00402	CcSEcCtD
Methysergide—Malaise—Etoposide—sarcoma	0.00199	0.004	CcSEcCtD
Methysergide—Abdominal pain—Thiotepa—sarcoma	0.00198	0.00399	CcSEcCtD
Methysergide—Body temperature increased—Thiotepa—sarcoma	0.00198	0.00399	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00197	0.00397	CcSEcCtD
Methysergide—Abdominal pain—Dactinomycin—sarcoma	0.00196	0.00396	CcSEcCtD
Methysergide—Body temperature increased—Dactinomycin—sarcoma	0.00196	0.00396	CcSEcCtD
Methysergide—Paraesthesia—Mitoxantrone—sarcoma	0.00194	0.00391	CcSEcCtD
Methysergide—HTR2A—tendon—sarcoma	0.00193	0.00383	CbGeAlD
Methysergide—Ataxia—Epirubicin—sarcoma	0.00193	0.00389	CcSEcCtD
Methysergide—Dyspnoea—Mitoxantrone—sarcoma	0.00193	0.00388	CcSEcCtD
Methysergide—Somnolence—Mitoxantrone—sarcoma	0.00192	0.00387	CcSEcCtD
Methysergide—Gastrointestinal disorder—Vincristine—sarcoma	0.00192	0.00386	CcSEcCtD
Methysergide—Fatigue—Vincristine—sarcoma	0.00191	0.00386	CcSEcCtD
Methysergide—Convulsion—Etoposide—sarcoma	0.00191	0.00385	CcSEcCtD
Methysergide—Dyspepsia—Mitoxantrone—sarcoma	0.0019	0.00384	CcSEcCtD
Methysergide—Pain—Vincristine—sarcoma	0.0019	0.00383	CcSEcCtD
Methysergide—Constipation—Vincristine—sarcoma	0.0019	0.00383	CcSEcCtD
Methysergide—Pain in extremity—Doxorubicin—sarcoma	0.0019	0.00382	CcSEcCtD
Methysergide—Chest pain—Etoposide—sarcoma	0.00188	0.00378	CcSEcCtD
Methysergide—Orthostatic hypotension—Epirubicin—sarcoma	0.00187	0.00378	CcSEcCtD
Methysergide—Fatigue—Mitoxantrone—sarcoma	0.00186	0.00376	CcSEcCtD
Methysergide—Discomfort—Etoposide—sarcoma	0.00185	0.00374	CcSEcCtD
Methysergide—Constipation—Mitoxantrone—sarcoma	0.00185	0.00373	CcSEcCtD
Methysergide—Pain—Mitoxantrone—sarcoma	0.00185	0.00373	CcSEcCtD
Methysergide—Gastrointestinal pain—Vincristine—sarcoma	0.00181	0.00366	CcSEcCtD
Methysergide—Asthenia—Thiotepa—sarcoma	0.0018	0.00362	CcSEcCtD
Methysergide—Ataxia—Doxorubicin—sarcoma	0.00178	0.0036	CcSEcCtD
Methysergide—Asthenia—Dactinomycin—sarcoma	0.00178	0.00359	CcSEcCtD
Methysergide—Feeling abnormal—Mitoxantrone—sarcoma	0.00178	0.00359	CcSEcCtD
Methysergide—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00177	0.00356	CcSEcCtD
Methysergide—Thrombocytopenia—Etoposide—sarcoma	0.00176	0.00355	CcSEcCtD
Methysergide—Tachycardia—Etoposide—sarcoma	0.00175	0.00354	CcSEcCtD
Methysergide—Eosinophilia—Epirubicin—sarcoma	0.00175	0.00354	CcSEcCtD
Methysergide—Body temperature increased—Vincristine—sarcoma	0.00175	0.00354	CcSEcCtD
Methysergide—Abdominal pain—Vincristine—sarcoma	0.00175	0.00354	CcSEcCtD
Methysergide—Orthostatic hypotension—Doxorubicin—sarcoma	0.00173	0.00349	CcSEcCtD
Methysergide—Diarrhoea—Thiotepa—sarcoma	0.00171	0.00345	CcSEcCtD
Methysergide—Body temperature increased—Mitoxantrone—sarcoma	0.00171	0.00344	CcSEcCtD
Methysergide—Abdominal pain—Mitoxantrone—sarcoma	0.00171	0.00344	CcSEcCtD
Methysergide—Diarrhoea—Dactinomycin—sarcoma	0.0017	0.00343	CcSEcCtD
Methysergide—Dysuria—Epirubicin—sarcoma	0.00166	0.00334	CcSEcCtD
Methysergide—Neutropenia—Epirubicin—sarcoma	0.00166	0.00334	CcSEcCtD
Methysergide—Dizziness—Thiotepa—sarcoma	0.00166	0.00334	CcSEcCtD
Methysergide—Eosinophilia—Doxorubicin—sarcoma	0.00162	0.00327	CcSEcCtD
Methysergide—Paraesthesia—Etoposide—sarcoma	0.00161	0.00325	CcSEcCtD
Methysergide—Weight increased—Epirubicin—sarcoma	0.00161	0.00325	CcSEcCtD
Methysergide—Weight decreased—Epirubicin—sarcoma	0.0016	0.00323	CcSEcCtD
Methysergide—Dyspnoea—Etoposide—sarcoma	0.0016	0.00323	CcSEcCtD
Methysergide—HTR2A—testis—sarcoma	0.0016	0.00317	CbGeAlD
Methysergide—Somnolence—Etoposide—sarcoma	0.0016	0.00322	CcSEcCtD
Methysergide—Asthenia—Vincristine—sarcoma	0.00159	0.00321	CcSEcCtD
Methysergide—Vomiting—Thiotepa—sarcoma	0.00159	0.00321	CcSEcCtD
Methysergide—Drowsiness—Epirubicin—sarcoma	0.00158	0.00319	CcSEcCtD
Methysergide—Vomiting—Dactinomycin—sarcoma	0.00158	0.00318	CcSEcCtD
Methysergide—Rash—Thiotepa—sarcoma	0.00158	0.00318	CcSEcCtD
Methysergide—Dermatitis—Thiotepa—sarcoma	0.00158	0.00318	CcSEcCtD
Methysergide—Rash—Dactinomycin—sarcoma	0.00157	0.00316	CcSEcCtD
Methysergide—Gastrointestinal disorder—Etoposide—sarcoma	0.00155	0.00313	CcSEcCtD
Methysergide—Asthenia—Mitoxantrone—sarcoma	0.00155	0.00313	CcSEcCtD
Methysergide—Fatigue—Etoposide—sarcoma	0.00155	0.00312	CcSEcCtD
Methysergide—Pain—Etoposide—sarcoma	0.00154	0.0031	CcSEcCtD
Methysergide—Constipation—Etoposide—sarcoma	0.00154	0.0031	CcSEcCtD
Methysergide—Dysuria—Doxorubicin—sarcoma	0.00153	0.00309	CcSEcCtD
Methysergide—Neutropenia—Doxorubicin—sarcoma	0.00153	0.00309	CcSEcCtD
Methysergide—Diarrhoea—Vincristine—sarcoma	0.00152	0.00306	CcSEcCtD
Methysergide—HTR2A—liver—sarcoma	0.00151	0.003	CbGeAlD
Methysergide—Weight increased—Doxorubicin—sarcoma	0.00149	0.00301	CcSEcCtD
Methysergide—Nausea—Thiotepa—sarcoma	0.00149	0.003	CcSEcCtD
Methysergide—Weight decreased—Doxorubicin—sarcoma	0.00148	0.00299	CcSEcCtD
Methysergide—Feeling abnormal—Etoposide—sarcoma	0.00148	0.00299	CcSEcCtD
Methysergide—Diarrhoea—Mitoxantrone—sarcoma	0.00148	0.00298	CcSEcCtD
Methysergide—Nausea—Dactinomycin—sarcoma	0.00148	0.00297	CcSEcCtD
Methysergide—Gastrointestinal pain—Etoposide—sarcoma	0.00147	0.00296	CcSEcCtD
Methysergide—Dizziness—Vincristine—sarcoma	0.00147	0.00296	CcSEcCtD
Methysergide—Drowsiness—Doxorubicin—sarcoma	0.00146	0.00295	CcSEcCtD
Methysergide—Abdominal pain—Etoposide—sarcoma	0.00142	0.00287	CcSEcCtD
Methysergide—Body temperature increased—Etoposide—sarcoma	0.00142	0.00287	CcSEcCtD
Methysergide—Vomiting—Vincristine—sarcoma	0.00141	0.00284	CcSEcCtD
Methysergide—Rash—Vincristine—sarcoma	0.0014	0.00282	CcSEcCtD
Methysergide—Dermatitis—Vincristine—sarcoma	0.0014	0.00282	CcSEcCtD
Methysergide—Oedema peripheral—Epirubicin—sarcoma	0.0014	0.00282	CcSEcCtD
Methysergide—Vomiting—Mitoxantrone—sarcoma	0.00137	0.00277	CcSEcCtD
Methysergide—Rash—Mitoxantrone—sarcoma	0.00136	0.00275	CcSEcCtD
Methysergide—Dermatitis—Mitoxantrone—sarcoma	0.00136	0.00274	CcSEcCtD
Methysergide—Nausea—Vincristine—sarcoma	0.00132	0.00266	CcSEcCtD
Methysergide—Flushing—Epirubicin—sarcoma	0.00132	0.00265	CcSEcCtD
Methysergide—Oedema peripheral—Doxorubicin—sarcoma	0.00129	0.00261	CcSEcCtD
Methysergide—Asthenia—Etoposide—sarcoma	0.00129	0.0026	CcSEcCtD
Methysergide—Nausea—Mitoxantrone—sarcoma	0.00128	0.00259	CcSEcCtD
Methysergide—Alopecia—Epirubicin—sarcoma	0.00125	0.00253	CcSEcCtD
Methysergide—Diarrhoea—Etoposide—sarcoma	0.00123	0.00248	CcSEcCtD
Methysergide—Flushing—Doxorubicin—sarcoma	0.00122	0.00246	CcSEcCtD
Methysergide—Back pain—Epirubicin—sarcoma	0.00119	0.00241	CcSEcCtD
Methysergide—Dizziness—Etoposide—sarcoma	0.00119	0.0024	CcSEcCtD
Methysergide—Alopecia—Doxorubicin—sarcoma	0.00116	0.00234	CcSEcCtD
Methysergide—Ill-defined disorder—Epirubicin—sarcoma	0.00115	0.00231	CcSEcCtD
Methysergide—Vomiting—Etoposide—sarcoma	0.00114	0.0023	CcSEcCtD
Methysergide—Rash—Etoposide—sarcoma	0.00113	0.00229	CcSEcCtD
Methysergide—Dermatitis—Etoposide—sarcoma	0.00113	0.00228	CcSEcCtD
Methysergide—Malaise—Epirubicin—sarcoma	0.00111	0.00224	CcSEcCtD
Methysergide—Back pain—Doxorubicin—sarcoma	0.00111	0.00223	CcSEcCtD
Methysergide—Convulsion—Epirubicin—sarcoma	0.00107	0.00216	CcSEcCtD
Methysergide—Nausea—Etoposide—sarcoma	0.00107	0.00215	CcSEcCtD
Methysergide—Ill-defined disorder—Doxorubicin—sarcoma	0.00106	0.00214	CcSEcCtD
Methysergide—Chest pain—Epirubicin—sarcoma	0.00105	0.00212	CcSEcCtD
Methysergide—Myalgia—Epirubicin—sarcoma	0.00105	0.00212	CcSEcCtD
Methysergide—Arthralgia—Epirubicin—sarcoma	0.00105	0.00212	CcSEcCtD
Methysergide—Discomfort—Epirubicin—sarcoma	0.00104	0.00209	CcSEcCtD
Methysergide—Malaise—Doxorubicin—sarcoma	0.00103	0.00208	CcSEcCtD
Methysergide—Oedema—Epirubicin—sarcoma	0.00101	0.00203	CcSEcCtD
Methysergide—Convulsion—Doxorubicin—sarcoma	0.00099	0.002	CcSEcCtD
Methysergide—Thrombocytopenia—Epirubicin—sarcoma	0.000987	0.00199	CcSEcCtD
Methysergide—Tachycardia—Epirubicin—sarcoma	0.000984	0.00198	CcSEcCtD
Methysergide—Chest pain—Doxorubicin—sarcoma	0.000973	0.00196	CcSEcCtD
Methysergide—Myalgia—Doxorubicin—sarcoma	0.000973	0.00196	CcSEcCtD
Methysergide—Arthralgia—Doxorubicin—sarcoma	0.000973	0.00196	CcSEcCtD
Methysergide—Discomfort—Doxorubicin—sarcoma	0.000961	0.00194	CcSEcCtD
Methysergide—Oedema—Doxorubicin—sarcoma	0.000933	0.00188	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000918	0.00185	CcSEcCtD
Methysergide—Thrombocytopenia—Doxorubicin—sarcoma	0.000913	0.00184	CcSEcCtD
Methysergide—Insomnia—Epirubicin—sarcoma	0.000912	0.00184	CcSEcCtD
Methysergide—Tachycardia—Doxorubicin—sarcoma	0.00091	0.00183	CcSEcCtD
Methysergide—Paraesthesia—Epirubicin—sarcoma	0.000905	0.00182	CcSEcCtD
Methysergide—Dyspnoea—Epirubicin—sarcoma	0.000899	0.00181	CcSEcCtD
Methysergide—Somnolence—Epirubicin—sarcoma	0.000896	0.00181	CcSEcCtD
Methysergide—Dyspepsia—Epirubicin—sarcoma	0.000887	0.00179	CcSEcCtD
Methysergide—Gastrointestinal disorder—Epirubicin—sarcoma	0.00087	0.00175	CcSEcCtD
Methysergide—Fatigue—Epirubicin—sarcoma	0.000869	0.00175	CcSEcCtD
Methysergide—Pain—Epirubicin—sarcoma	0.000862	0.00174	CcSEcCtD
Methysergide—Constipation—Epirubicin—sarcoma	0.000862	0.00174	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00085	0.00171	CcSEcCtD
Methysergide—Insomnia—Doxorubicin—sarcoma	0.000843	0.0017	CcSEcCtD
Methysergide—Paraesthesia—Doxorubicin—sarcoma	0.000837	0.00169	CcSEcCtD
Methysergide—Dyspnoea—Doxorubicin—sarcoma	0.000831	0.00168	CcSEcCtD
Methysergide—Feeling abnormal—Epirubicin—sarcoma	0.000831	0.00167	CcSEcCtD
Methysergide—Somnolence—Doxorubicin—sarcoma	0.000829	0.00167	CcSEcCtD
Methysergide—Gastrointestinal pain—Epirubicin—sarcoma	0.000824	0.00166	CcSEcCtD
Methysergide—Dyspepsia—Doxorubicin—sarcoma	0.000821	0.00165	CcSEcCtD
Methysergide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000805	0.00162	CcSEcCtD
Methysergide—Fatigue—Doxorubicin—sarcoma	0.000804	0.00162	CcSEcCtD
Methysergide—Pain—Doxorubicin—sarcoma	0.000797	0.00161	CcSEcCtD
Methysergide—Constipation—Doxorubicin—sarcoma	0.000797	0.00161	CcSEcCtD
Methysergide—Body temperature increased—Epirubicin—sarcoma	0.000797	0.00161	CcSEcCtD
Methysergide—Abdominal pain—Epirubicin—sarcoma	0.000797	0.00161	CcSEcCtD
Methysergide—Feeling abnormal—Doxorubicin—sarcoma	0.000768	0.00155	CcSEcCtD
Methysergide—Gastrointestinal pain—Doxorubicin—sarcoma	0.000763	0.00154	CcSEcCtD
Methysergide—Abdominal pain—Doxorubicin—sarcoma	0.000737	0.00149	CcSEcCtD
Methysergide—Body temperature increased—Doxorubicin—sarcoma	0.000737	0.00149	CcSEcCtD
Methysergide—Asthenia—Epirubicin—sarcoma	0.000723	0.00146	CcSEcCtD
Methysergide—Diarrhoea—Epirubicin—sarcoma	0.00069	0.00139	CcSEcCtD
Methysergide—Asthenia—Doxorubicin—sarcoma	0.000669	0.00135	CcSEcCtD
Methysergide—Dizziness—Epirubicin—sarcoma	0.000666	0.00134	CcSEcCtD
Methysergide—Vomiting—Epirubicin—sarcoma	0.000641	0.00129	CcSEcCtD
Methysergide—Diarrhoea—Doxorubicin—sarcoma	0.000638	0.00129	CcSEcCtD
Methysergide—Rash—Epirubicin—sarcoma	0.000635	0.00128	CcSEcCtD
Methysergide—Dermatitis—Epirubicin—sarcoma	0.000635	0.00128	CcSEcCtD
Methysergide—Dizziness—Doxorubicin—sarcoma	0.000617	0.00124	CcSEcCtD
Methysergide—Nausea—Epirubicin—sarcoma	0.000599	0.00121	CcSEcCtD
Methysergide—Vomiting—Doxorubicin—sarcoma	0.000593	0.0012	CcSEcCtD
Methysergide—Rash—Doxorubicin—sarcoma	0.000588	0.00119	CcSEcCtD
Methysergide—Dermatitis—Doxorubicin—sarcoma	0.000587	0.00118	CcSEcCtD
Methysergide—Nausea—Doxorubicin—sarcoma	0.000554	0.00112	CcSEcCtD
